Reviewing Cannlabs (OTCMKTS:CANL) and Pediatrix Medical Group (NYSE:MD)

Cannlabs (OTCMKTS:CANL) and Pediatrix Medical Group (NYSE:MD) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, profitability, dividends, risk, valuation, earnings and institutional ownership.

Earnings and Valuation

This table compares Cannlabs and Pediatrix Medical Group”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cannlabs	N/A	N/A	N/A	N/A	N/A
Pediatrix Medical Group	$2.01 billion	0.93	-$99.07 million	$1.90	11.53

Cannlabs has higher earnings, but lower revenue than Pediatrix Medical Group.

Institutional & Insider Ownership

97.7% of Pediatrix Medical Group shares are held by institutional investors. 0.9% of Pediatrix Medical Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Cannlabs and Pediatrix Medical Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Cannlabs	N/A	N/A	N/A
Pediatrix Medical Group	8.44%	20.45%	7.94%

Analyst Ratings

This is a breakdown of current recommendations and price targets for Cannlabs and Pediatrix Medical Group, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cannlabs	0	0	0	0	0.00
Pediatrix Medical Group	0	4	1	1	2.50

Pediatrix Medical Group has a consensus target price of $21.00, suggesting a potential downside of 4.11%. Given Cannlabs’ higher probable upside, analysts clearly believe Cannlabs is more favorable than Pediatrix Medical Group.

Risk and Volatility

Cannlabs has a beta of 1.75, meaning that its stock price is 75% more volatile than the S&P 500. Comparatively, Pediatrix Medical Group has a beta of 0.73, meaning that its stock price is 27% less volatile than the S&P 500.

Summary

Pediatrix Medical Group beats Cannlabs on 9 of the 11 factors compared between the two stocks.

About Cannlabs

CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. was incorporated in 2010 and is based in Denver, Colorado.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.